Implantable cardioverter defibrillators in paediatric patients: yet another example of healthcare divergence?

Affiliations

¹ Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
² Children's Heart Centre, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
³ Boise St. Luke's Pediatric Cardiology, Boise ID and Division of Pediatric Cardiology Department of Pediatrics, Stanford University, Stanford, CA, USA.

Editorial

Elizabeth DeWitt et al. Europace. 2024.

. 2024 Aug 30;26(9):euae230.

doi: 10.1093/europace/euae230.

¹ Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
² Children's Heart Centre, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
³ Boise St. Luke's Pediatric Cardiology, Boise ID and Division of Pediatric Cardiology Department of Pediatrics, Stanford University, Stanford, CA, USA.

Erratum in

Correction to: Implantable cardioverter defibrillators in paediatric patients: yet another example of healthcare divergence?
[No authors listed] [No authors listed] Europace. 2024 Nov 1;26(11):euae276. doi: 10.1093/europace/euae276. Europace. 2024. PMID: 39504492 Free PMC article. No abstract available.

No abstract available

1. Cacciola S. Team USA Says Air-Conditioners Are a ‘High-Performance Decision’—The New York Times. https://www.nytimes.com/2024/06/27/style/olympics-air-conditioners.html (27 June 2024).
1. Baskar S, Bao H, Minges KE, Spar DS, Czosek RJ. Characteristics and outcomes of pediatric patients who undergo placement of implantable cardioverter defibrillators: insights from the national cardiovascular data registry. Circ Arrhythm Electrophysiol 2018;11:e006542. - PubMed
1. Suzuki T, Sumitomo N, Yoshimoto J, Miyazaki A, Hinokiyama K, Ushinohama Het al. . Current trends in use of implantable cardioverter defibrillators and cardiac resynchronization therapy with a pacemaker or defibrillator in Japanese pediatric patients—results from a nationwide questionnaire survey. Circ J 2014;78:1710–6. - PubMed
1. Balaji S, DiLorenzo MP, Fish FA, Etheridge SP, Aziz PF, Russell MWet al. . Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: an international multicenter study. Heart Rhythm 2019;16:1462–467. - PubMed
1. Nauffal V, Marstrand P, Han L, Parikh VN, Helms AS, Ingles Jet al. . Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy. Eur Heart J 2021;42:3932–944. - PMC - PubMed